Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Clin Exp Metastasis. 2019 May 9;36(3):211–224. doi: 10.1007/s10585-019-09967-0

Figure 1. Isoforms of glutaminase have opposing roles in cancer metastasis.

Figure 1.

Glutaminase 1 increases tumor cell survival via its canonical catalytic activity. Opposingly glutaminase 2 inhibits tumor metastasis and EMT via its secondary functions as a binding protein (Details in text). EMT (Epithelial-Mesenchymal Transition); Rac1 (Ras-related C3 botulinum toxin substrate 1)